Detalles de la búsqueda
1.
The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: the KYUCOG-1401-A study.
Prostate Cancer Prostatic Dis;
2024 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38368501
2.
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.
Int J Urol;
31(4): 362-369, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38148124
3.
Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study.
Endocr Relat Cancer;
30(7)2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079309
4.
Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study.
Int J Clin Oncol;
27(10): 1632-1643, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948732
5.
Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study.
BJUI Compass;
3(1): 26-36, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35475157
6.
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial.
Cancer Med;
10(10): 3240-3248, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932114
7.
Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer.
Int J Urol;
28(2): 208-214, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33283389
8.
A randomized phase III trial of personalized peptide vaccination for castrationresistant prostate cancer progressing after docetaxel.
Oncol Rep;
45(1): 159-168, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33200227
9.
Effect of Smoking on Oncological Outcome among Prostate Cancer Patients after Radical Prostatectomy with Neoadjuvant Hormonal Therapy.
Cancer Invest;
38(10): 559-564, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33016145
10.
Impact of antiandrogen withdrawal syndrome in castration-resistant prostate cancer patients treated with abiraterone or enzalutamide.
Int J Urol;
27(12): 1109-1115, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32929792
11.
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial.
Cancer;
126(17): 3961-3971, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573779
12.
Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.
Int J Clin Oncol;
25(6): 1163-1169, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125546
13.
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.
Cancer Immunol Immunother;
69(5): 847-857, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32025848
14.
Family history in primary hormone therapy for prostate cancer: Analysis from a community-based multi-institutional Japan-wide database.
Int J Urol;
27(4): 313-318, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037622
15.
Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401).
Eur Urol;
77(6): 689-698, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31866092
16.
Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer.
Anticancer Res;
39(8): 4325-4328, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31366524
17.
Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: Outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS).
Brachytherapy;
18(6): 806-813, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31378511
18.
Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
J Urol;
202(6): 1127-1135, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31251717
19.
Clinical Outcomes in Patients With Metastatic Papillary Renal-Cell Carcinoma: A Multi-Institutional Study in Japan.
Clin Genitourin Cancer;
16(6): e1201-e1214, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30224330
20.
Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching.
Cancer Med;
7(10): 4893-4902, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30151999